Oncology & Cancer

Stage III/IV melanoma patients at risk for new primaries

(HealthDay)—Patients with stage III or IV melanoma who have not received treatment with BRAF inhibitors remain at risk for developing new primary melanomas (NPMs), although the incidence rates are lower than those observed ...

Diseases, Conditions, Syndromes

Spatiotemporal analysis emphasizes value of vaccination

(HealthDay)—Spatiotemporal data emphasizes the importance of vaccination programs, according to research published in the Nov. 28 issue of the New England Journal of Medicine.

Diseases, Conditions, Syndromes

Fewer cases of antibiotic-resistant MRSA infection in the US in 2011

An estimated 30,800 fewer invasive methicillin-resistant Staphylococcus aureus (MRSA) infections occurred in the United States in 2011 compared to 2005, according to a study in JAMA Internal Medicine by Raymund Dantes, M.D., ...

Arthritis & Rheumatism

Tofacitinib ups rheumatoid arthritis treatment response

(HealthDay)—The addition of tofacitinib to rheumatoid arthritis (RA) treatment regimens improves patient response to non-biologic disease-modifying antirheumatic drugs (DMARDs), according to a study published in the Aug. ...

page 30 from 40